Home/Akros Pharma/Kala Patel, R.Ph.,RAC.
KP

Kala Patel, R.Ph.,RAC.

Senior Director, Regulatory Affairs

Akros Pharma

Akros Pharma Pipeline

DrugIndicationPhase
JTE-051Autoimmune diseases, Allergic diseasesPhase2
JTT-662Type 2 diabetes mellitusPhase1
JTT-861Chronic heart failurePhase2
JTC-064Neurodegenerative diseasePhase1
JTV-161Pulmonary arterial hypertensionPhase1
JTE-162Autoinflammatory/Autoimmune diseasesPhase1
JTC-262Neurodegenerative diseasePhase1
JTV-263Peripheral artery diseasePhase1